- Home
- CPIX vs ALGS Comparison
CPIX vs ALGS Comparison
Compare CPIX & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPIX
- ALGS
- Stock Information
- Founded
- CPIX 1999
- ALGS 2018
- Country
- CPIX United States
- ALGS United States
- Employees
- CPIX N/A
- ALGS N/A
- Industry
- CPIX Biotechnology: Pharmaceutical Preparations
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- CPIX Health Care
- ALGS Health Care
- Exchange
- CPIX Nasdaq
- ALGS Nasdaq
- Market Cap
- CPIX 46.2M
- ALGS 53.0M
- IPO Year
- CPIX 2009
- ALGS 2020
- Fundamental
- Price
- CPIX $3.64
- ALGS $9.68
- Analyst Decision
- CPIX
- ALGS Strong Buy
- Analyst Count
- CPIX 0
- ALGS 2
- Target Price
- CPIX N/A
- ALGS $60.00
- AVG Volume (30 Days)
- CPIX 24.8K
- ALGS 72.0K
- Earning Date
- CPIX 11-06-2025
- ALGS 11-05-2025
- Dividend Yield
- CPIX N/A
- ALGS N/A
- EPS Growth
- CPIX N/A
- ALGS N/A
- EPS
- CPIX N/A
- ALGS N/A
- Revenue
- CPIX $42,071,813.00
- ALGS $3,174,000.00
- Revenue This Year
- CPIX N/A
- ALGS N/A
- Revenue Next Year
- CPIX N/A
- ALGS N/A
- P/E Ratio
- CPIX N/A
- ALGS N/A
- Revenue Growth
- CPIX 11.34
- ALGS N/A
- 52 Week Low
- CPIX $1.04
- ALGS $3.76
- 52 Week High
- CPIX $7.25
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- CPIX 54.53
- ALGS 50.93
- Support Level
- CPIX $3.08
- ALGS $9.66
- Resistance Level
- CPIX $3.61
- ALGS $10.64
- Average True Range (ATR)
- CPIX 0.21
- ALGS 0.70
- MACD
- CPIX 0.04
- ALGS -0.02
- Stochastic Oscillator
- CPIX 73.80
- ALGS 42.32
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.